What are lower urinary tract symptoms?

LUTS, or lower urinary tract symptoms, is a term used to describe a range of urinary symptoms and may include: frequency, urgency, incontinence, nocturia, dysuria, recurrent urinary tract infection (UTI), hesitancy, weak stream, and incomplete emptying.

LUTS encompasses dysfunctions in bladder storage, voiding or both. The International Prostate Symptom Score (IPSS) is designed for the assessment and diagnosis of LUTS and evaluation of treatment outcomes.

Dysfunctions of storage include:

  • Bladder capacity
  • Bladder compliance
  • Overactive bladder (OAB) = Presence of phasic contractions (also called detrusor instability)
  • Urethral incompetence
  • Incontinence (urge, stress, mixed)

Dysfunctions in voiding include:

  • Bladder neck and urethral function
  • Urethral diverticulum
  • Vesicoureteral reflux
  • Obstruction
  • Intrinsic sphincter deficiency
  • Detrusor weakness

Urologic Testing

A urologic exam includes detailed patient history, physical assessment, patient diary (frequency/volume charts), and urodynamic testing (filling/voiding studies).

Urodynamics is the general term for the study of the storage and voiding function/dysfunction of the lower urinary tract. This includes one or more of the following:

  • Filling cystometry
  • Uroflowmetry
  • Flow/pressure study
    • Bladder pressure during filling (storage) and voiding
    • Obstruction when the pressure in the bladder is high and the flow rate of urine is low
  • Electromyography (EMG): looks at the coordination between bladder muscle contraction and sphincter relaxation (detrusor sphincter dyssynergia)
  • Videocystourethography (VCUG): x-ray imaging

NIRS Approach

The NIRS bladder monitor system applies near infrared spectroscopy (NIRS) technology to monitor hemodynamic changes in the microcirculation of the bladder detrusor muscle during voiding. This is used to detect characteristic changes in health and disease, and provides a real-time, non-invasive evaluation of bladder function to aid in the diagnosis of bladder outlet obstruction (BOO). The diagnosis is made with the use of a uroflowmeter (for measuring the maximum urinary flow rate, Qmax) and ultrasound devices (for measuring postvoid residual volume, PVR).

This breakthrough technology provides urologists with clinically relevant information about the health and function of the bladder without the use of invasive catheter-based tests.


Currently Urodynamix has two systems in use worldwide:

Tetra™ Bladder Monitor System is a system developed by Urodynamix and distributed worldwide by Laborie Medical Technologies Inc. as an accessory to Laborie's premium urodynamics equipment. It allows for the non-invasive monitoring of bladder function to aid in the diagnosis of BOO.

uroNIRS 2000™ Bladder Monitor System is a wireless standalone tablet PC-based device specifically designed for ease of use in the physician’s office setting. The system is compact and portable.

This non-invasive NIRS procedure is easier, faster, less expensive and more comfortable for patients than conventional invasive urodynamic studies (UDS).It eliminates the use of catheters and the associated complications, fear, and pain [1], [2],

Clinical studies have shown that the uroNIRS bladder monitor has 86% sensitivity and 89% specificity for detecting BOO compared to conventional UDS [4].

  

References:

[1] Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol. 1998 Jan; 159(1):191-4

[2] Greenstein A, Bar-Yosef Y, Chen J, Matzkin H. Does information provided to men before a urodynamic study affect their expectation of pain? BJU Int. 2005 Dec; 96(9):1307-9

[3] Choe JH, Lee JS, Seo JT. Urodynamic studies in women with stress urinary incontinence: Significant bacteriuria and risk factors. Neurourol Urodyn. 2007;26(6):847-51

[4] Macnab AJ, Stothers L. Near-infrared Spectroscopy: Validation of bladder-outlet obstruction assessment using non-invasive parameters. Can J Urol. 2008; 15(5): 4241-4248